A review of blood samples for nearly 5,000 patients seen at one American hospital suggests that federal guidelines for hepatitis C virus screening may be missing up to a quarter of all cases and argues for updated universal screening.
A review of blood samples for nearly 5,000 patients seen at one American hospital suggests that federal guidelines for hepatitis C virus screening may be missing up to a quarter of all cases and argues for updated universal screening.